510(k) Report

De Novo · Granted

Granted

Iogyn System

DEN130040De NovoGranted Mar 28, 2014210-day reviewClass II21 CFR 884.1710

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iogyn, Inc. · PGT Insufflator, Hysteroscopic, Fluid, Closed-Loop Recirculation With Cutter-Coagulator, Endoscopic, Bipolar

Granted on Mar 28, 2014 as a new device type through De Novo after a 210-day review. 2 later devices descend from it.

Decided
Mar 28, 2014
Review
210 days
Class
Class II
Product code
PGT
Recalls
None

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2014: 1 descendant cleared2024: 1 descendant cleared2010201520202025
  1. This deviceDEN130040 Iogyn SystemIogyn, Inc. · 2014
  2. Descendant · cites it directly · 1 of its ownK141848 Iogyn SystemIogyn, Inc. · 2014
  3. Descendant · 2 generations on · 0 of its ownK233710 Symphion Operative Hysteroscopy SystemMinerva Surgical, Inc. · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K141848Iogyn SystemIogyn, Inc. · 2014 · cites it directly1descendant
  • K233710Symphion Operative Hysteroscopy SystemMinerva Surgical, Inc. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN130040Iogyn SystemIogyn, Inc.2014—
+1K141848Iogyn SystemIogyn, Inc.2014—
+2K233710Symphion Operative Hysteroscopy SystemMinerva Surgical, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
202410
FIG. 1 — Lineage of DEN130040, 2014–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PGT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PGT device

  1. #1 K233710 Symphion Operative Hysteroscopy Systemscore 8.8 · 8 generations · no Class I recall
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K141848Iogyn SystemIogyn, Inc.20141

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K141848 (Iogyn, Inc., 2014) has gone furthest, with 1 descendant of its own.

How does its category compare?

All PGT devices

PGT Insufflator, Hysteroscopic, Fluid, Closed-Loop Recirculation With Cutter-Coagulator, Endoscopic, Bipolar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · PGT

1in 2024

2014: 22024: 1
2007high 2 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PGT

Too few PGT 510(k)s in any year since 2007 to give a median.

Recalls per year · PGT

No recall names PGT since 2007.

Adverse event reports per year · PGT

1in 2025

2015: 72016: 192017: 392018: 172019: 132020: 72021: 52022: 12023: 52024: 22025: 1
2007high 39 (2017) · low 0 (2007)2025

MAUDE reports naming product code PGT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20142—00
20150—07
20160—019
20170—039
20180—017
20190—013
20200—07
20210—05
20220—01
20230—05
20241—02
20250—01
20260—0—

What is it indicated for?

The IOGYN System, a prescription device under 21 CFR Part 801.109 that is indicated for distension of the uterus by filling it with saline to facilitate viewing with a hysteroscope during diagnostic and operative hysteroscopy and provide fluid management through the closed loop recirculation of filtered distension fluid. It is also intended for cutting and coagulation of uterine tissue such as intrauterine polyps and myomas using a bipolar resecting device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN130040: Iogyn System.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN130040

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026